Central nervous system toxicity after botulinum neurotoxin injection.
Since Its first description of botulism toxicity in 1820s, specific formulations of botulinum neurotoxin (BoNT) have been introduced with different clinical benefits. However, there is increasing number of adverse events reported to Food and Drug Administration. This report presents the case of 62-year-old woman with Parkinson's disease who received BoNT injections to treat painful spasticity in her hands. She developed severe generalized dystonia shortly after BoNT injections.
Department of Anesthesiology and Critical Care Medicine, School of Medicine, University of New Mexico, Albuquerque, USA.
Yashar
Y
Ilkhchoui
Ramsis F
RF
Ghaly
N Nick
NN
Knezevic
Kenneth D
KD
Candido
Botulinum Toxins, Type A; Dystonic Disorders; Pain; Parkinson Disease